National Research Corporation
NRC
$18.10
$0.100.56%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 139.10M | 140.31M | 141.30M | 143.06M | 144.15M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 139.10M | 140.31M | 141.30M | 143.06M | 144.15M |
| Cost of Revenue | 52.79M | 55.69M | 56.13M | 56.93M | 56.38M |
| Gross Profit | 86.32M | 84.63M | 85.16M | 86.13M | 87.78M |
| SG&A Expenses | 51.79M | 50.51M | 44.00M | 44.89M | 44.53M |
| Depreciation & Amortization | 7.00M | 6.35M | 6.12M | 6.02M | 5.94M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 111.57M | 112.54M | 106.25M | 107.85M | 106.84M |
| Operating Income | 27.53M | 27.77M | 35.05M | 35.21M | 37.31M |
| Income Before Tax | 23.45M | 24.48M | 32.22M | 32.69M | 35.28M |
| Income Tax Expenses | 7.09M | 6.55M | 8.01M | 7.91M | 8.20M |
| Earnings from Continuing Operations | 16.36 | 17.93 | 24.21 | 24.78 | 27.08 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.36M | 17.93M | 24.21M | 24.78M | 27.08M |
| EBIT | 27.53M | 27.77M | 35.05M | 35.21M | 37.31M |
| EBITDA | 34.53M | 34.12M | 41.17M | 41.24M | 43.25M |
| EPS Basic | 0.70 | 0.76 | 1.03 | 1.05 | 1.13 |
| Normalized Basic EPS | 0.64 | 0.66 | 0.86 | 0.86 | 0.92 |
| EPS Diluted | 0.70 | 0.76 | 1.03 | 1.05 | 1.13 |
| Normalized Diluted EPS | 0.64 | 0.66 | 0.86 | 0.86 | 0.92 |
| Average Basic Shares Outstanding | 91.11M | 92.71M | 93.92M | 94.81M | 95.90M |
| Average Diluted Shares Outstanding | 91.13M | 92.74M | 94.00M | 94.99M | 96.17M |
| Dividend Per Share | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 |
| Payout Ratio | 67.82% | 62.39% | 46.75% | 46.22% | 42.77% |